VIVANI MED.INC. NEW O.N. (U5P) - Total Assets
Based on the latest financial reports, VIVANI MED.INC. NEW O.N. (U5P) holds total assets worth €39.39 Million EUR (≈ $46.05 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
VIVANI MED.INC. NEW O.N. - Total Assets Trend (2021–2025)
This chart illustrates how VIVANI MED.INC. NEW O.N.'s total assets have evolved over time, based on quarterly financial data. Also see U5P stock market capitalisation for the company's overall valuation and market capitalisation.
VIVANI MED.INC. NEW O.N. - Asset Composition Analysis
Current Asset Composition (December 2025)
VIVANI MED.INC. NEW O.N.'s total assets of €39.39 Million consist of 45.4% current assets and 54.6% non-current assets. Review VIVANI MED.INC. NEW O.N. total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 41.2% |
| Accounts Receivable | €0.00 | 0.0% |
| Inventory | €0.00 | 0.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €0.00 | 0.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how VIVANI MED.INC. NEW O.N.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See U5P share price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: VIVANI MED.INC. NEW O.N.'s current assets represent 45.4% of total assets in 2025, an increase from 45.3% in 2021.
- Cash Position: Cash and equivalents constituted 41.2% of total assets in 2025, up from 39.9% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
VIVANI MED.INC. NEW O.N. Competitors by Total Assets
Key competitors of VIVANI MED.INC. NEW O.N. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Tubize-Fin
BR:TUB
|
Belgium | €1.99 Billion |
|
Dianthus Therapeutics Inc.
NASDAQ:DNTH
|
USA | $1.21 Billion |
|
Tango Therapeutics Inc
NASDAQ:TNGX
|
USA | $1.07 Billion |
|
Damora Therapeutics, Inc.
NASDAQ:DMRA
|
USA | $543.64 Million |
|
Apnimed, Inc. Common Stock
NASDAQ:APMD
|
USA | $342.63 Million |
|
Wecome Pharmaceutical Co Ltd
SHE:300878
|
China | CN¥1.49 Billion |
|
Tectonic Therapeutic, Inc.
NASDAQ:TECX
|
USA | $246.58 Million |
|
Relmada Therapeutics Inc
NASDAQ:RLMD
|
USA | $235.36 Million |
VIVANI MED.INC. NEW O.N. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.71 | 3.41 | 3.41 |
| Quick Ratio | 2.71 | 3.41 | 3.41 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €11.30 Million | €14.46 Million | €15.13 Million |
VIVANI MED.INC. NEW O.N. - Advanced Valuation Insights
This section examines the relationship between VIVANI MED.INC. NEW O.N.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.04 |
| Latest Market Cap to Assets Ratio | 2.01 |
| Asset Growth Rate (YoY) | -5.2% |
| Total Assets | €39.39 Million |
| Market Capitalization | $79.34 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values VIVANI MED.INC. NEW O.N.'s assets at a significant premium (2.01x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: VIVANI MED.INC. NEW O.N.'s assets decreased by 5.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for VIVANI MED.INC. NEW O.N. (2021–2025)
The table below shows the annual total assets of VIVANI MED.INC. NEW O.N. from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €39.39 Million ≈ $46.05 Million |
-5.22% |
| 2024-12-31 | €41.56 Million ≈ $48.59 Million |
-9.25% |
| 2023-12-31 | €45.80 Million ≈ $53.54 Million |
-10.43% |
| 2022-12-31 | €51.13 Million ≈ $59.78 Million |
+837.65% |
| 2021-12-31 | €5.45 Million ≈ $6.38 Million |
-- |
About VIVANI MED.INC. NEW O.N.
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the t… Read more